Mitsui-7, heat-treated, and nitrogen-doped multi-walled carbon nanotubes elicit genotoxicity in human lung epithelial cells.
Aneuploidy
Carbon nanotubes
Cell cycle
Centromere
Chromosomal translocations
Genotoxicity
In vitro
Mitotic spindle
Journal
Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354
Informations de publication
Date de publication:
07 10 2019
07 10 2019
Historique:
received:
19
03
2019
accepted:
19
08
2019
entrez:
9
10
2019
pubmed:
9
10
2019
medline:
24
6
2020
Statut:
epublish
Résumé
The unique physicochemical properties of multi-walled carbon nanotubes (MWCNT) have led to many industrial applications. Due to their low density and small size, MWCNT are easily aerosolized in the workplace making respiratory exposures likely in workers. The International Agency for Research on Cancer designated the pristine Mitsui-7 MWCNT (MWCNT-7) as a Group 2B carcinogen, but there was insufficient data to classify all other MWCNT. Previously, MWCNT exposed to high temperature (MWCNT-HT) or synthesized with nitrogen (MWCNT-ND) have been found to elicit attenuated toxicity; however, their genotoxic and carcinogenic potential are not known. Our aim was to measure the genotoxicity of MWCNT-7 compared to these two physicochemically-altered MWCNTs in human lung epithelial cells (BEAS-2B & SAEC). Dose-dependent partitioning of individual nanotubes in the cell nuclei was observed for each MWCNT material and was greatest for MWCNT-7. Exposure to each MWCNT led to significantly increased mitotic aberrations with multi- and monopolar spindle morphologies and fragmented centrosomes. Quantitative analysis of the spindle pole demonstrated significantly increased centrosome fragmentation from 0.024-2.4 μg/mL of each MWCNT. Significant aneuploidy was measured in a dose-response from each MWCNT-7, HT, and ND; the highest dose of 24 μg/mL produced 67, 61, and 55%, respectively. Chromosome analysis demonstrated significantly increased centromere fragmentation and translocations from each MWCNT at each dose. Following 24 h of exposure to MWCNT-7, ND and/or HT in BEAS-2B a significant arrest in the G1/S phase in the cell cycle occurred, whereas the MWCNT-ND also induced a G2 arrest. Primary SAEC exposed for 24 h to each MWCNT elicited a significantly greater arrest in the G1 and G2 phases. However, SAEC arrested in the G1/S phase after 72 h of exposure. Lastly, a significant increase in clonal growth was observed one month after exposure to 0.024 μg/mL MWCNT-HT & ND. Although MWCNT-HT & ND cause a lower incidence of genotoxicity, all three MWCNTs cause the same type of mitotic and chromosomal disruptions. Chromosomal fragmentation and translocations have not been observed with other nanomaterials. Because in vitro genotoxicity is correlated with in vivo genotoxic response, these studies in primary human lung cells may predict the genotoxic potency in exposed human populations.
Sections du résumé
BACKGROUND
The unique physicochemical properties of multi-walled carbon nanotubes (MWCNT) have led to many industrial applications. Due to their low density and small size, MWCNT are easily aerosolized in the workplace making respiratory exposures likely in workers. The International Agency for Research on Cancer designated the pristine Mitsui-7 MWCNT (MWCNT-7) as a Group 2B carcinogen, but there was insufficient data to classify all other MWCNT. Previously, MWCNT exposed to high temperature (MWCNT-HT) or synthesized with nitrogen (MWCNT-ND) have been found to elicit attenuated toxicity; however, their genotoxic and carcinogenic potential are not known. Our aim was to measure the genotoxicity of MWCNT-7 compared to these two physicochemically-altered MWCNTs in human lung epithelial cells (BEAS-2B & SAEC).
RESULTS
Dose-dependent partitioning of individual nanotubes in the cell nuclei was observed for each MWCNT material and was greatest for MWCNT-7. Exposure to each MWCNT led to significantly increased mitotic aberrations with multi- and monopolar spindle morphologies and fragmented centrosomes. Quantitative analysis of the spindle pole demonstrated significantly increased centrosome fragmentation from 0.024-2.4 μg/mL of each MWCNT. Significant aneuploidy was measured in a dose-response from each MWCNT-7, HT, and ND; the highest dose of 24 μg/mL produced 67, 61, and 55%, respectively. Chromosome analysis demonstrated significantly increased centromere fragmentation and translocations from each MWCNT at each dose. Following 24 h of exposure to MWCNT-7, ND and/or HT in BEAS-2B a significant arrest in the G1/S phase in the cell cycle occurred, whereas the MWCNT-ND also induced a G2 arrest. Primary SAEC exposed for 24 h to each MWCNT elicited a significantly greater arrest in the G1 and G2 phases. However, SAEC arrested in the G1/S phase after 72 h of exposure. Lastly, a significant increase in clonal growth was observed one month after exposure to 0.024 μg/mL MWCNT-HT & ND.
CONCLUSIONS
Although MWCNT-HT & ND cause a lower incidence of genotoxicity, all three MWCNTs cause the same type of mitotic and chromosomal disruptions. Chromosomal fragmentation and translocations have not been observed with other nanomaterials. Because in vitro genotoxicity is correlated with in vivo genotoxic response, these studies in primary human lung cells may predict the genotoxic potency in exposed human populations.
Identifiants
pubmed: 31590690
doi: 10.1186/s12989-019-0318-0
pii: 10.1186/s12989-019-0318-0
pmc: PMC6781364
doi:
Substances chimiques
Nanotubes, Carbon
0
Nitrogen
N762921K75
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
36Subventions
Organisme : NIOSH CDC HHS
ID : 927Z8V
Pays : United States
Organisme : NIOSH CDC HHS
ID : 927ZLDA
Pays : United States
Organisme : NIOSH CDC HHS
ID : 939011N
Pays : United States
Références
Nucleic Acids Res. 2006 Aug 02;34(13):3670-6
pubmed: 16885240
Toxicology. 2015 Jul 3;333:25-36
pubmed: 25797581
Cancer Sci. 2016 Jul;107(7):924-35
pubmed: 27098557
Cell Cycle. 2013 May 15;12(10):1588-97
pubmed: 23624842
J Occup Health. 2010;52(3):155-66
pubmed: 20379079
Toxicology. 2010 Mar 10;269(2-3):136-47
pubmed: 19857541
Mol Cancer. 2011 Oct 19;10:131
pubmed: 22011530
Int J Nanomedicine. 2014 Apr 17;9:1979-90
pubmed: 24790438
J Phys Conf Ser. 2013;429(12029):
pubmed: 26300949
Part Fibre Toxicol. 2014 Jan 30;11:6
pubmed: 24479647
Basic Clin Pharmacol Toxicol. 2019 Feb;124(2):211-227
pubmed: 30168672
Toxicol Sci. 2003 Aug;74(2):287-96
pubmed: 12773761
Int J Nanomedicine. 2012;7:5577-91
pubmed: 23144561
Small. 2009 Mar;5(3):310-5
pubmed: 19148890
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Trends Biotechnol. 2008 Jun;26(6):302-10
pubmed: 18433902
Genet Med. 2006 Jan;8(1):16-23
pubmed: 16418595
Genet Med. 2011 Jul;13(7):667-75
pubmed: 21738013
Am J Respir Cell Mol Biol. 1993 Aug;9(2):186-91
pubmed: 8393329
J Toxicol Environ Health A. 2014;77(22-24):1399-408
pubmed: 25343289
Lancet Oncol. 2014 Dec;15(13):1427-1428
pubmed: 25499275
Inflammation. 2010 Aug;33(4):276-80
pubmed: 20174859
Toxicol Appl Pharmacol. 2015 Apr 1;284(1):16-32
pubmed: 25554681
Cell. 2011 Jun 24;145(7):1062-74
pubmed: 21703450
J Occup Health. 2016 Nov 29;58(6):622-631
pubmed: 27725379
Trends Cell Biol. 2011 Jun;21(6):374-81
pubmed: 21306900
Nanotoxicology. 2013 Sep;7(6):1157-67
pubmed: 22812632
Nat Commun. 2016 Aug 31;7:12619
pubmed: 27577169
ACS Nano. 2012 Aug 28;6(8):6614-25
pubmed: 22769231
Nanotoxicology. 2014 May;8(3):317-27
pubmed: 23432020
ACS Nano. 2007 Nov;1(4):369-75
pubmed: 19206689
J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):275-83
pubmed: 15557800
Small. 2011 Nov 18;7(22):3230-8
pubmed: 21919194
Nat Rev Genet. 2012 Jan 24;13(3):189-203
pubmed: 22269907
J Mol Diagn. 2007 Apr;9(2):134-43
pubmed: 17384204
Mutat Res. 2012 Jun 14;745(1-2):28-37
pubmed: 22178868
Inhal Toxicol. 2014 Mar;26(4):222-34
pubmed: 24568578
Pathol Int. 2013 Sep;63(9):457-62
pubmed: 24200157
Nat Rev Cancer. 2007 Dec;7(12):911-24
pubmed: 18004399
Mutat Res. 2011 May 18;722(1):20-31
pubmed: 21382506
Environ Mol Mutagen. 2015 Mar;56(2):183-203
pubmed: 25393212
Toxicol Pathol. 2018 Jan;46(1):28-46
pubmed: 28929951
Nat Commun. 2018 Oct 18;9(1):4340
pubmed: 30337534
J Appl Toxicol. 2009 Jan;29(1):69-78
pubmed: 18756589
Nanotoxicology. 2014 Aug;8(5):485-507
pubmed: 23634900
Adv Exp Med Biol. 2005;570:393-421
pubmed: 18727509
Toxicology. 2013 Nov 8;313(1):24-37
pubmed: 23266321
Carcinogenesis. 2005 Apr;26(4):725-31
pubmed: 15677631
Inhal Toxicol. 2010 Apr;22(5):369-81
pubmed: 20121582
J Toxicol Environ Health A. 2013;76(18):1056-71
pubmed: 24188191
Inhal Toxicol. 2001 Sep;13(9):755-72
pubmed: 11570360
Trends Cell Biol. 2015 Jan;25(1):21-8
pubmed: 25220181
Cancer Detect Prev. 1993;17(6):567-73
pubmed: 8275509
Cell Cycle. 2005 Aug;4(8):1007-10
pubmed: 16082199
Nanotoxicology. 2011 Dec;5(4):711-29
pubmed: 21073401
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19658-63
pubmed: 17167055
J Toxicol Environ Health A. 2004 Jan 9;67(1):87-107
pubmed: 14668113
Methods Cell Biol. 2001;67:325-36
pubmed: 11550478
Nature. 2003 Aug 28;424(6952):1074-8
pubmed: 12904818
Am J Ind Med. 2012 May;55(5):395-411
pubmed: 22392774
Part Fibre Toxicol. 2006 Nov 29;3:15
pubmed: 17134509
Environ Health Perspect. 2008 Dec;116(12):1689-93
pubmed: 19079721
Trends Cell Biol. 2005 Jun;15(6):303-11
pubmed: 15953548
Toxicol Appl Pharmacol. 2005 Sep 15;207(3):221-31
pubmed: 16129115
Carcinogenesis. 1995 Nov;16(11):2751-8
pubmed: 7586195
Environ Mol Mutagen. 2009 Oct;50(8):708-17
pubmed: 19774611
Nat Cell Biol. 2014 May;16(5):386-94
pubmed: 24914434
Part Fibre Toxicol. 2014 Jan 09;11:3
pubmed: 24405760
Risk Anal. 2014 Mar;34(3):583-97
pubmed: 24024907
Carcinogenesis. 2008 Feb;29(2):427-33
pubmed: 18174261
Nano Lett. 2006 Aug;6(8):1609-16
pubmed: 16895344
Nanotoxicology. 2013 Jun;7(4):452-61
pubmed: 22397533
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1330-8
pubmed: 22084097
Genes Environ. 2015 Jun 16;37:6
pubmed: 27350803
Part Fibre Toxicol. 2013 Oct 21;10(1):53
pubmed: 24144386
BMC Cancer. 2016 Jan 29;16:47
pubmed: 26832928
Am J Pathol. 2011 Jun;178(6):2587-600
pubmed: 21641383
Nanotoxicology. 2016 Nov;10(9):1263-75
pubmed: 27323647
Part Fibre Toxicol. 2014 Nov 20;11:59
pubmed: 25410479
Part Fibre Toxicol. 2016 Oct 13;13(1):53
pubmed: 27737701
Nanotoxicology. 2010 Jun;4(2):207-46
pubmed: 20795897
Exp Cell Res. 2007 Oct 1;313(16):3635-44
pubmed: 17643424
Toxicol In Vitro. 2014 Feb;28(1):60-9
pubmed: 23811260
J Occup Environ Med. 2011 Jun;53(6 Suppl):S62-7
pubmed: 21654420
Ann Occup Hyg. 2015 Jul;59(6):705-23
pubmed: 25851309
ACS Nano. 2010 Dec 28;4(12):7637-43
pubmed: 21070008
Inhal Toxicol. 2008 Jun;20(8):741-9
pubmed: 18569096
J Occup Health. 2018 Jan 25;60(1):10-30
pubmed: 29046510
J Occup Environ Hyg. 2012;9(9):543-55
pubmed: 22816668
Nanotechnology. 2010 Jan 8;21(1):015102
pubmed: 19946169
Toxicol Sci. 2015 Mar;144(1):114-27
pubmed: 25505129